Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on BOD Australia.
RELATED STOCKHEAD STORIES
Experts
CRITERION: Thinking of risking a finger on a falling knife? Sometimes they come back…
Health & Biotech
Weed Week: Cannabis boom a ‘matter of when, not if’; and NSW to allow residents to grow pot
Health & Biotech
Why these ASX firms are shying away from the pot stock label – Part Two
News
10 at 11ish: Identified pegmatites spur Golden State Mining to kick off drilling at Paynes Find
Health & Biotech
ASX Health Stocks: BOD says all trials are done, and it’s time to begin commercialising Aqua Phase
Health & Biotech
Clinical results for ancient therapy help ASX cannabis stocks weed out competition
Health & Biotech
Weed Week: Growing excitement for cannabis stocks after marijuana rescheduling hopes in the US
News
In Case You Missed It: Irish wave energy deal and a plethora of placements
News
ASX Health Stocks: Bod Science surges 20pc on cannabis trial results; Recce gets Vietnam trade mark
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: Data centres, gold and cannabis take the lead
Health & Biotech
ASX Health Stocks: BOD to acquire Aqua Phase on positive data; Bionomics set to delist
Health & Biotech
Weed Week: Social media platforms scramble to update advertising policies on cannabis products
Health & Biotech
How Bod Science pulled ahead in the race for Australia’s first over-the-counter CBD
Health & Biotech
ASX Health Stocks: Bod Science provides ‘landmark update’, while Incannex prepares to list on Nasdaq
Health & Biotech
ASX Health Stocks: BOD to sell cannabis in Malaysia; AHI explores the burgeoning Middle East e-script market
News